Related Experiment Videos
Imaging of brain tumors using peripheral benzodiazepine receptor ligands
K L Black1, K Ikezaki, A W Toga
1Division of Neurosurgery, University of California School of Medicine, Los Angeles.
Abstract:
Peripheral benzodiazepine receptor ligands were utilized to selectively image intracerebrally implanted C6 gliomas, RG-2 gliomas, and Walker 256 metastatic tumors by means of quantitative autoradiography. Intravenous injections of 3H-PK11195 (1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide) or 3H-flunitrazepam in combination with clonazepam revealed high densities of peripheral benzodiazepine binding in glial tumors, with less binding in metastatic tumors. Peripheral binding was displaced by preadministration of excess PK11195. Topographical correlation was excellent between areas of histologically verified tumor and high densities of peripheral benzodiazepine binding. The choroid plexus, ependyma, and pineal gland also showed a moderate level of binding, but there was little binding in other normal brain structures or necrotic tissue. Binding densities were three- to fivefold higher in C6 glial tumors compared to normal cortex. Injection of 3H-flunitrazepam alone, which binds to both central and peripheral receptors, had the advantage of showing normal anatomic structures in addition to a clear definition of tumor topography. The potential value of peripheral benzodiazepine ligands in selectively imaging brain tumors in man with positron emission tomography is discussed.
Insights
Peripheral benzodiazepine receptor ligands show high binding in glial tumors, aiding selective imaging. This study highlights their potential for diagnosing brain tumors using positron emission tomography.
Area of Science:
- Neuroscience
- Oncology
- Radiology
Background:
- Peripheral benzodiazepine receptors (PBRs) are implicated in various cellular processes.
- Selective imaging of brain tumors remains a challenge in clinical diagnostics.
Purpose of the Study:
- To evaluate the utility of peripheral benzodiazepine receptor ligands for selectively imaging intracerebral tumors.
- To assess the binding characteristics of PBR ligands in different tumor types and normal brain structures.
Main Methods:
- Quantitative autoradiography was employed to analyze the binding of radiolabeled PBR ligands (3H-PK11195 and 3H-flunitrazepam) in animal models.
- Tumor models included C6 gliomas, RG-2 gliomas, and Walker 256 metastatic tumors.
- Binding specificity was confirmed by displacement studies with excess PK11195.
Main Results:
- High densities of peripheral benzodiazepine binding were observed in glial tumors (C6 and RG-2) and metastatic tumors (Walker 256).
- Glial tumors exhibited significantly higher binding (3-5 fold) compared to normal brain cortex.
- Excellent topographical correlation was found between tumor histology and PBR binding.
- Specific PBR ligands demonstrated selective uptake in tumors, with minimal binding in normal brain structures and necrotic tissue.
- 3H-flunitrazepam alone provided visualization of both normal anatomy and tumor topography.
Conclusions:
- Peripheral benzodiazepine receptor ligands effectively target and image intracerebral tumors, particularly glial tumors.
- These ligands hold significant potential for the selective diagnosis of brain tumors using positron emission tomography (PET).
- Further investigation is warranted to translate these findings to human clinical applications.